SAN DIEGO, July 23, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
